Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Bruun LD, Andersen GØ, Kringen MK, Myhre PL, Halvorsen S, Hansen CH, Molden E, Øie E(2025) Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study Eur J Clin Pharmacol(in press) DOI 10.1007/s00228-025-03806-w, PubMed 39900827
Alver TN, Bergholtz H, Holm MB, Dorg LT, Skrede ML, Kure EH, Verbeke CS(2025) Spatial transcriptomics reveals cancer and stromal cell heterogeneity between center and invasive front of pancreatic cancer Mod Pathol, 100726(in press) DOI 10.1016/j.modpat.2025.100726, PubMed 39889965
Engseth LHW, Øhrn FD, Schulz A, Röhrl SM(2025) CT-based migration analysis of a tibial component compared to radiostereometric analysis : one-year results of a prospective single-group implant safety study Bone Joint J, 107-B(2), 173-180 DOI 10.1302/0301-620X.107B2.BJJ-2024-0356.R2, PubMed 39889761